Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. National Institute for Clinical Excellence. 2002. (Record no. 11039)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00732cam a2200241 4500 |
001 - CONTROL NUMBER | |
control field | A020941 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 090401t2002 xxu||||| |||| 00| 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 1842571583 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Sirsi) i9781842571583 |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
Classification number | WE 346. |
110 ## - MAIN ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | Nice |
245 ## - TITLE STATEMENT | |
Title | Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. National Institute for Clinical Excellence. 2002. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Name of publisher, distributor, etc. | NICE, |
Date of publication, distribution, etc. | 2002 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 22p |
500 ## - GENERAL NOTE | |
General note | Technology Appraisal Guidance No. 36. |
591 ## - | |
-- | P |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Arthritis, rheumatoid |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Drug therapy |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Clinical effectiveness |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Evidence based practice |
710 ## - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | National Inst Clinical Excellence |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Suppress in OPAC | Do not Suppress in OPAC |
No items available.